603 related articles for article (PubMed ID: 27056366)
1. Cell-free circulating tumor DNA in cancer.
Qin Z; Ljubimov VA; Zhou C; Tong Y; Liang J
Chin J Cancer; 2016 Apr; 35():36. PubMed ID: 27056366
[TBL] [Abstract][Full Text] [Related]
2. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
3. The feasibility of using mutation detection in ctDNA to assess tumor dynamics.
Yi X; Ma J; Guan Y; Chen R; Yang L; Xia X
Int J Cancer; 2017 Jun; 140(12):2642-2647. PubMed ID: 28124376
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection.
Sumbal S; Javed A; Afroze B; Zulfiqar HF; Javed F; Noreen S; Ijaz B
Exp Hematol; 2018 Sep; 65():17-28. PubMed ID: 29940219
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma.
Calapre L; Warburton L; Millward M; Ziman M; Gray ES
Cancer Lett; 2017 Sep; 404():62-69. PubMed ID: 28687355
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Gingras I; Salgado R; Ignatiadis M
Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
[TBL] [Abstract][Full Text] [Related]
9. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor DNA as a liquid biopsy for cancer.
Heitzer E; Ulz P; Geigl JB
Clin Chem; 2015 Jan; 61(1):112-23. PubMed ID: 25388429
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
Chen X; Wang L; Lou J
Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
[TBL] [Abstract][Full Text] [Related]
12. Advances in Circulating Tumor DNA Analysis.
Perakis S; Auer M; Belic J; Heitzer E
Adv Clin Chem; 2017; 80():73-153. PubMed ID: 28431643
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
Ignatiadis M; Lee M; Jeffrey SS
Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
[TBL] [Abstract][Full Text] [Related]
15. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review.
Parimi S; Ko JJ
Expert Rev Anticancer Ther; 2017 Oct; 17(10):939-949. PubMed ID: 28737470
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsies.
Lianidou E; Pantel K
Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
Gao Y; Zhu Y; Yuan Z
Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
[TBL] [Abstract][Full Text] [Related]
20. Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.
Cheng H; Liu C; Jiang J; Luo G; Lu Y; Jin K; Guo M; Zhang Z; Xu J; Liu L; Ni Q; Yu X
Int J Cancer; 2017 May; 140(10):2344-2350. PubMed ID: 28205231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]